These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69. Anistreplase for acute coronary thrombosis. Med Lett Drugs Ther; 1990 Feb; 32(812):15-6. PubMed ID: 2406552 [No Abstract] [Full Text] [Related]
70. [A case of pulmonary artery thrombosis due to catheterization of right subclavian vein in female patient with myocardial infarction]. Lisin VV; Bochkareva LE; Kirillov MM; Moiseeva VI; Pikaliuk ID Klin Med (Mosk); 1998; 76(1):58-9. PubMed ID: 9532920 [No Abstract] [Full Text] [Related]
71. The evolution of antithrombotic treatments in myocardial infarction. de Nicola P New Istanbul Contrib Clin Sci; 1972 Dec; 10(3):142-6. PubMed ID: 4670447 [No Abstract] [Full Text] [Related]
72. ED slashes treatment time for heart attack drugs. Patient Focus Care Satisf; 1999 Mar; 7(3):30-2. PubMed ID: 10346206 [No Abstract] [Full Text] [Related]
73. [Looking back the progress and debates of anti-thrombotic therapies in 2009]. Shi ZW Zhonghua Nei Ke Za Zhi; 2010 Jun; 49(6):460-2. PubMed ID: 20979728 [No Abstract] [Full Text] [Related]
74. CA-7, a fibrinolytic enzyme from Aspergillus oryzae. Can Med Assoc J; 1968 Apr; 98(16):789-90. PubMed ID: 5646120 [No Abstract] [Full Text] [Related]
75. How can adherence to guidelines be improved? The case of fibrinolytics. Nicolau JC Sao Paulo Med J; 2001 Nov; 119(6):192. PubMed ID: 11723532 [No Abstract] [Full Text] [Related]